Health on MSN1d
What To Know About HR+/HER2- Breast Cancer
Medically reviewed by Marla Anderson, MD HR+/HER2- breast cancer—or hormone receptor-positive, HER2-negative breast cancer—is ...
Where Does Breast Cancer Most Commonly Spread?
The peritoneal cavity, which contains the abdominal organs, is a less common but still potential site for breast cancer to ...
Philecia La'Bounty on the Impact Sharing Her Breast Cancer Journey Has Had on Others: 'They Are So Grateful'
Philecia La'Bounty uses social media to encourage others to get screenings, be open about their experiences and share her own battles — and her followers have shown appreciation. Read more about her ...
AstraZeneca's metastatic breast cancer treatment gets EU recommendation
AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo said on Friday that the European Medicines Agency (EMA) endorsed ENHERTU for the ...
Woman Who Received a '36 Month Expiration Date' Cancer Diagnosis 14 Years Ago Now Focuses on Plans for the Future
Stephanie Seban has devoted the last 14 years of her life to being a 'north star' to other young women facing stage four ...
Too Old to Operate2d
Prognostic Relevance of HER2-Low Status in Breast Cancer
The following is a summary of "HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials ...
Pharm Exec1d
AstraZeneca’s Camizestrant Shows Survival Improvement for HR-Positive, HER2-Negative Advanced Breast Cancer with Emergent ESR1 Mutations
The Phase III SERENA-6 trial is the first global trial to use a circulating tumor DNA-guided approach to detect endocrine ...
Cure Today1d
Metronomic Capecitabine and an AI Improve Survival in HR+/HER2– Metastatic Breast Cancer
Metronomic capecitabine plus an aromatase inhibitor improved survival outcomes in hormone receptor-positive, HER2-negative ...
Cure Today2d
Delving Into Clinical Research For Patients With Breast Cancer
Regarding patients with HER2-negative, estrogen receptor (ER)-positive breast cancer, the phase 3 KEYNOTE-756 study is ...
AstraZeneca therapy improves breast cancer survival in key trial
Drugmaker AstraZeneca on Wednesday said that its experimental breast cancer treatment improved patient survival without the ...
The American Journal of Managed Care4h
How Pharmacists Can Help Patients Navigate Costs, Access to Breast Cancer Therapies
Tiffany Meng, PharmD, oncology pharmacist, UCSF Health, discusses ways that pharmacists can help guide patients to financial ...
Breast Cancer Market Sees Rapid Growth — Key Insights and Forecasts of Different Breast Cancers for the Coming 10 Years | DelveInsight
The breast cancer market has experienced robust growth, fueled by increased awareness and early detection efforts. Advances in diagnostic and treatment technologies have opened new avenues for ...